How to Decrease Bronchopulmonary Dysplasia in Your Neonatal Intensive Care Unit Today and "Tomorrow"

F1000Res. 2017 Apr 21;6:539. doi: 10.12688/f1000research.10832.1. eCollection 2017.

Abstract

Bronchopulmonary dysplasia, or BPD, is the most common chronic lung disease in infants. Genetic predisposition and developmental vulnerability secondary to antenatal and postnatal infections, compounded with exposure to hyperoxia and invasive mechanical ventilation to an immature lung, result in persistent inflammation, culminating in the characteristic pulmonary phenotype of BPD of impaired alveolarization and dysregulated vascularization. In this article, we highlight specific areas in current management, and speculate on therapeutic strategies that are on the horizon, that we believe will make an impact in decreasing the incidence of BPD in your neonatal intensive care units.

Keywords: BPD; bronchopulmonary dysplasia; neonatal intensive care.

Publication types

  • Review

Grant support

The author(s) declared that no grants were involved in supporting this work.